1 of 1
HOUSE DOCKET, NO. 2700 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 1190
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Natalie M. Higgins
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to modern family building.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Natalie M. Higgins4th Worcester1/16/2025Lindsay N. Sabadosa1st Hampshire1/21/2025James B. EldridgeMiddlesex and Worcester2/8/2025Jason M. LewisFifth Middlesex2/14/2025 1 of 17
HOUSE DOCKET, NO. 2700 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 1190
By Representative Higgins of Leominster, a petition (accompanied by bill, House, No. 1190) of
Natalie M. Higgins and others relative to fertility diagnostic care. Financial Services.
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act relative to modern family building.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 SECTION 1. Section 17T of chapter 32A of the General Laws, as appearing in section 74
2of chapter 140 of the acts of 2024, is hereby amended by inserting after the word "processes”, in
3subsection (b), the following words:- , provided that such storage shall be covered from the date
4of cryopreservation until the individual reaches the age of 35, or for a period of not less than five
5years, whichever is later.
6 SECTION 2. Said chapter 32A is hereby amended by inserting after section 17T the
7following section:-
8 Section 17U. (a) For purposes of this section, the following terms shall have the
9following meanings unless the context clearly requires otherwise:
10 “Fertility diagnostic care”, procedures, products, genetic testing, medications and
11services intended to provide information and counseling about an individual’s fertility, including
12laboratory assessments and imaging studies. 2 of 17
13 “Fertility treatment”, procedures, products, genetic testing, medications and services,
14including but not limited to in vitro fertilization, intended to achieve a pregnancy that results in a
15live birth and that are provided in a manner consistent with established medical practice and
16professional guidelines published by the American Society for Reproductive Medicine, its
17successor organization, or a comparable organization, including preconception care,
18procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue.
19 “Infertility”, any of the following: (i) a licensed physician’s findings, based on a patient’s
20medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any
21combination of these factors; (ii) the need for medical intervention, including, but not limited to,
22the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as
23an individual or with a partner; or (iii) the inability to establish a pregnancy after regular,
24unprotected sexual intercourse for a period of no more than twelve months for an intended
25gestational parent under the age of 35 and of no more than 6 months for an intended gestational
26parent who is 35 years of age or older, provided that pregnancy resulting in miscarriage or
27stillbirth does not restart said 12-month or 6-month time period, (iv) an individual’s increased
28risk, independently or with the individual’s partner, of transmitting a serious, inheritable genetic
29or chromosomal abnormality to a child; or (v) as otherwise defined by the American Society of
30Reproductive Medicine or its successor organization.
31 (b) The commission shall provide to any active or retired employee of the commonwealth
32who is insured under the group insurance commission coverage, to the same extent that benefits
33are provided for other pregnancy-related procedures, coverage for fertility diagnostic care and
34fertility treatment for individuals residing within the commonwealth diagnosed with infertility as
35defined in subsection (a), performed by any licensed medical providers acting within the scope 3 of 17
36of practice for their profession, including physicians, nurse practitioners, certified nurse-
37midwives and licensed certified professional midwives. No conditions, including but not limited
38to prior treatment, age, sexual orientation, gender identity or familial status, shall be imposed to
39receive benefits under this section.
40 (c) A policy that provides coverage for services required under this section shall cover: (i)
41no fewer than four completed oocyte retrievals; (ii) unlimited embryo transfers from retrievals
42covered under this section or from any other completed oocyte retrieval; (iii) unlimited cycles of
43intrauterine insemination; and (iv) unlimited intracervical insemination. No policy shall be
44required to provide coverage for any nonmedical costs relating to the procurement of gametes,
45donor embryos, or surrogacy services.
46 (d) Said coverage may not include any of the following: (i) any exclusion, limitation or
47other restriction on coverage of fertility medications that are different from those imposed on
48other prescription medications; (ii) any exclusion or denial of coverage of any fertility treatment
49based on a covered individual’s participation in fertility services provided by a third party,
50including gestational carriers, surrogates and the donation or use of said thirty party’s genetic
51material; and (iii) any deductible, copayment, coinsurance, benefit maximum or other limitation
52on coverage for services rendered pursuant to this section that are different from those imposed
53upon services not relating to infertility or fertility treatment.
54 SECTION 3. Chapter 112 of the General Laws is hereby amended by inserting after
55section 5O the following section:-
56 Section 5P. (a) The bureau of health professions licensure shall, in collaboration with
57experts in lesbian, gay, bisexual, transgender and queer, hereinafter LGBTQ, family building, 4 of 17
58and in coordination with the American Society for Reproductive Medicine or the Society for
59Assisted Reproductive Technology, develop or provide for, and make available to the board of
60registration in medicine, the board of registration in midwifery, the board of registration in
61nursing and any clinical laboratories licensed under 105 CMR 140.000 that collects, stores or
62distributes any genetic material for fertility treatment a professional development training
63module regarding resources and services available to LGBTQ couples seeking to expand their
64families. The goal of the training module shall be to encourage physicians to speak with their
65patients, and to increase a physician's competency in having effective discussions with patients
66and families in an appropriate manner. The training module shall include information on: (i) the
67prevention and elimination of discrimination based on sexual orientation, gender identity and
68expression in medical settings; (ii) improving access to services for LGBTQ individuals; and (iii)
69options for LGBTQ individuals seeking to start or grow their family.
70 (b) The training module developed shall be accepted by the board of registration in
71medicine, the board of registration in midwifery and the board of registration in nursing as up to
722 continuing professional development credits.
73 SECTION 4. Chapter 118E of the General Laws is hereby amended by inserting after
74section 10A1/2 the following section:-
75 Section 10AA. The division shall provide coverage for fertility diagnostic care, any
76medically necessary ovulation-enhancing drugs and medical services related to prescribing and
77monitoring the use of ovulation-enhancing drugs, and intrauterine insemination that is intended
78to treat infertility and achieve a pregnancy that results in a live birth that includes at least 3 5 of 17
79cycles of ovulation-enhancing medication treatment over a medical assistance recipient’s
80lifetime.
81 SECTION 5. Chapter 175 of the General Laws is hereby amended by striking out section
8247H, as appearing in the 2022 Official Edition, and inserting in place thereof the following
83section:-
84 Section 47H. (a) For purposes of this section, the following terms shall have the
85following meanings unless the context clearly requires otherwise:
86 “Fertility diagnostic care”, procedures, products, genetic testing, medications and
87services intended to provide information and counseling about an individual’s fertility, including
88laboratory assessments and imaging studies.
89 “Fertility treatment”, procedures, products, genetic testing, medications and services,
90including but not limited to in vitro fertilization, intended to achieve a pregnancy that results in a
91live birth and that are provided in a manner consistent with established medical practice and
92professional guidelines published by the American Society for Reproductive Medicine, its
93successor organization, or a comparable organization, including preconception care,
94procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue.
95 “Infertility”, any of the following: (i) a licensed physician’s findings, based on a patient’s
96medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any
97combination of these factors; (ii) the need for medical intervention, including, but not limited to,
98the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as
99an individual or with a partner; or (iii) the inability to establish a pregnancy after regular,
100unprotected sexual intercourse for a period of no more than twelve months for an intended 6 of 17
101gestational parent under the age of 35 and of no more than 6 months for an intended gestational
102parent who is 35 years of age or older, provided that pregnancy resulting in miscarriage or
103stillbirth does not restart said 12-month or 6-month time period, (iv) an individual’s increased
104risk, independently or with the individual’s partner, of transmitting a serious, inheritable genetic
105or chromosomal abnormality to a child; or (v) as otherwise defined by the American Society of
106Reproductive Medicine or its successor organization.
107 (b) Any blanket or general policy of insurance, except a blanket or general policy of
108insurance which provides supplemental coverage to medicare or other governmental programs,
109described in subsections (a), (c) or (d) of section 110 that provides hospital expense or surgical
110expense insurance that includes pregnancy-related benefits and is issued or subsequently
111renewed by agreement between the insurer and the policyholder, within or without the
112commonwealth, while this provision is effective, or any policy of accident and sickness
113insurance as described in section one hundred and eight that provides hospital expense or
114surgical expense insurance that includes pregnancy-related benefits and is delivered or issued for
115delivery or subsequently renewed by agreement between the insurer and the policyholder in the
116commonwealth while this provision is effective, or any employees' health and welfare fund that
117provides hospital expense and surgical expense benefits that includes pregnancy-related benefits
118and is promulgated or renewed to any person or group of persons in the commonwealth while
119this provision is effective shall provide, to the same extent that benefits are provided for other
120pregnancy-related procedures, coverage for fertility diagnostic care and fertility treatment for
121individuals residing within the commonwealth diagnosed with infertility as defined in subsection
122(a), performed by any licensed medical providers acting within the scope of practice for their 7 of 17
123profession, including physicians, nurse practitioners, certified nurse-midwives and licensed
124certified professional midwives.
125 (c) A policy that provides coverage for services required under this section shall cover: (i)
126no fewer than four completed oocyte retrievals; (ii) unlimited embryo transfers from retrievals
127covered under this section or from any other completed oocyte retrieval; (iii) unlimited cycles of
128intrauterine insemination; and (iv) unlimited intracervical insemination. No policy shall be
129required to provide coverage for any nonmedical costs relating to the procurement of gametes,
130donor embryos, or surrogacy services.
131 (d) Said coverage may not include any of the following: (i) any exclusion, limitation or
132other restriction on coverage of fertility medications that are different from those imposed on
133other prescription medications; (ii) any exclusion or denial of coverage of any fertility treatment
134based on a covered individual’s participation in fertility services provided by a third party,
135including gestational carriers, surrogates and the donation or use of said thirty party’s genetic
136material; and (iii) any deductible, copayment, coinsurance, benefit maximum or other limitation
137on coverage for services rendered pursuant to this section that are different from those imposed
138upon services not relating to infertility or fertility treatment.
139 SECTION 6. Section 47VV of said chapter 175, as appearing in section 145 of chapter
140140 of the acts of 2024, is hereby amended by inserting after the word “tissue”, in subsection (b),
141the following words:- , provided that coverage for such storage shall extend until the individual
142reaches the age of 35, or for a period of 5 years, whichever is later
143 SECTION 7. Chapter 176A of the General Laws is hereby amended by striking section
1448K, as appearing in the 2022 Official Edition, and inserting in place thereof the following:- 8 of 17
145 Section 8K. (a) For purposes of this section, the following terms shall have the following
146meanings unless the context clearly requires otherwise:
147 “Fertility diagnostic care”, procedures, products, genetic testing, medications and
148services intended to provide information and counseling about an individual’s fertility, including
149laboratory assessments and imaging studies.
150 “Fertility treatment”, procedures, products, genetic testing, medications and services,
151including but not limited to in vitro fertilization, intended to achieve a pregnancy that results in a
152live birth and that are provided in a manner consistent with established medical practice and
153professional guidelines published by the American Society for Reproductive Medicine, its
154successor organization, or a comparable organization, including preconception care,
155procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue.
156 “Infertility”, any of the following: (i) a licensed physician’s findings, based on a patient’s
157medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any
158combination of these factors; (ii) the need for medical intervention, including, but not limited to,
159the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as
160an individual or with a partner; or (iii) the inability to establish a pregnancy after regular,
161unprotected sexual intercourse for a period of no more than twelve months for an intended
162gestational parent under the age of 35 and of no more than 6 months for an intended gestational
163parent who is 35 years of age or older, provided that pregnancy resulting in miscarriage or
164stillbirth does not restart said 12-month or 6-month time period, (iv) an individual’s increased
165risk, independently or with the individual’s partner, of transmitting a serious, inheritable genetic 9 of 17
166or chromosomal abnormality to a child; or (v) as otherwise defined by the American Society of
167Reproductive Medicine or its successor organization.
168 (b) Any contract, except contracts providing supplemental coverage to medicare or other
169governmental programs, between a subscriber and the corporation under an individual or group
170hospital service plan which is delivered, issued for delivery or renewed in the commonwealth
171while this provision is effective and that provides pregnancy-related benefits shall provide as a
172benefit for all individual subscribers or members within the commonwealth and all group
173members having a principal place of employment within the commonwealth, to the same extent
174that benefits are provided for other pregnancy-related procedures, coverage for fertility
175diagnostic care and fertility treatment for individuals residing within the commonwealth
176diagnosed with infertility as defined in subsection (a), performed by any licensed medical
177providers acting within the scope of practice for their profession, including physicians, nurse
178practitioners, certified nurse-midwives and licensed certified professional midwives.
179 (c) A policy that provides coverage for services required under this section shall cover: (i)
180no fewer than four completed oocyte retrievals; (ii) unlimited embryo transfers from retrievals
181covered under this section or from any other completed oocyte retrieval; (iii) unlimited cycles of
182intrauterine insemination; and (iv) unlimited intracervical insemination. No policy shall be
183required to provide coverage for any nonmedical costs relating to the procurement of gametes,
184donor embryos, or surrogacy services.
185 (d) Said coverage may not include any of the following: (i) any exclusion, limitation or
186other restriction on coverage of fertility medications that are different from those imposed on
187other prescription medications; (ii) any exclusion or denial of coverage of any fertility treatment 10 of 17
188based on a covered individual’s participation in fertility services provided by a third party,
189including gestational carriers, surrogates and the donation or use of said thirty party’s genetic
190material; and (iii) any deductible, copayment, coinsurance, benefit maximum or other limitation
191on coverage for services rendered pursuant to this section that are different from those imposed
192upon services not relating to infertility or fertility treatment.
193 SECTION 8. Section 8WW of said chapter 176A, as appearing in section 148 of chapter
194140 of the acts of 2024, is hereby amended by inserting after the word “tissue”, in subsection (b),
195the following words:- , provided that coverage for such storage shall extend until the individual
196reaches the age of 35, or for a period of 5 years, whichever is later
197 SECTION 9. Chapter 176B of the General Laws is hereby amended by striking out
198section 4J, as appearing in the 2022 Official Edition, and inserting in place thereof the following
199new section:-
200 Section 4J. (a) For purposes of this section, the following terms shall have the following
201meanings unless the context clearly requires otherwise:
202 “Fertility diagnostic care”, procedures, products, genetic testing, medications and
203services intended to provide information and counseling about an individual’s fertility, including
204laboratory assessments and imaging studies.
205 “Fertility treatment”, procedures, products, genetic testing, medications and services,
206including but not limited to in vitro fertilization, intended to achieve a pregnancy that results in a
207live birth and that are provided in a manner consistent with established medical practice and
208professional guidelines published by the American Society for Reproductive Medicine, its 11 of 17
209successor organization, or a comparable organization, including preconception care,
210procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue.
211 “Infertility”, any of the following: (i) a licensed physician’s findings, based on a patient’s
212medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any
213combination of these factors; (ii) the need for medical intervention, including, but not limited to,
214the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as
215an individual or with a partner; or (iii) the inability to establish a pregnancy after regular,
216unprotected sexual intercourse for a period of no more than twelve months for an intended
217gestational parent under the age of 35 and of no more than 6 months for an intended gestational
218parent who is 35 years of age or older, provided that pregnancy resulting in miscarriage or
219stillbirth does not restart said 12-month or 6-month time period, (iv) an individual’s increased
220risk, independently or with the individual’s partner, of transmitting a serious, inheritable genetic
221or chromosomal abnormality to a child; or (v) as otherwise defined by the American Society of
222Reproductive Medicine or its successor organization.
223 (b) Any subscription certificate under an individual or group medical service agreement,
224except certificates which provide supplemental coverage to medicare or other governmental
225programs, which is delivered, issued for delivery or renewed in the commonwealth while this
226section is effective shall provide as a benefit for all individual subscribers or members within the
227commonwealth and all group members having a principal place of employment within the
228commonwealth, to the same extent that benefits are provided for other pregnancy-related
229procedures and subject to the other terms and conditions of the subscription certificate, coverage
230for fertility diagnostic care and fertility treatment for individuals residing within the
231commonwealth diagnosed with infertility as defined in subsection (a), performed by any licensed 12 of 17
232medical providers acting within the scope of practice for their profession, including physicians,
233nurse practitioners, certified nurse-midwives and licensed certified professional midwives.
234 (c) A policy that provides coverage for services required under this section shall cover: (i)
235no fewer than four completed oocyte retrievals; (ii) unlimited embryo transfers from retrievals
236covered under this section or from any other completed oocyte retrieval; (iii) unlimited cycles of
237intrauterine insemination; and (iv) unlimited intracervical insemination. No policy shall be
238required to provide coverage for any nonmedical costs relating to the procurement of gametes,
239donor embryos, or surrogacy services.
240 (d) Said coverage may not include any of the following: (i) any exclusion, limitation or
241other restriction on coverage of fertility medications that are different from those imposed on
242other prescription medications; (ii) any exclusion or denial of coverage of any fertility treatment
243based on a covered individual’s participation in fertility services provided by a third party,
244including gestational carriers, surrogates and the donation or use of said thirty party’s genetic
245material; and (iii) any deductible, copayment, coinsurance, benefit maximum or other limitation
246on coverage for services rendered pursuant to this section that are different from those imposed
247upon services not relating to infertility or fertility treatment.
248 SECTION 10. Section 4WW of said chapter 176B, as appearing in section 149 of chapter
249140 of the acts of 2024, is hereby amended by inserting after the word “tissue”, in subsection (b),
250the following words:- , provided that coverage for such storage shall extend until the individual
251reaches the age of 35, or for a period of 5 years, whichever is later
252 SECTION 11. (a) The office of health equity shall investigate, analyze and study the
253affordability, accessibility and practicality of the resources and services available to lesbian, gay, 13 of 17
254bisexual, transgender and queer, hereinafter LGBTQ, individuals and couples seeking to expand
255their families and to make recommendations to improve access to benefits and services where
256necessary. The office shall: (i) examine availability of assisted reproduction providers in rural
257and geographically isolated areas; (ii) assess the funding and programming needed to enhance
258services to the growing population LGBTQ parents; (iii) examine the feasibility of developing
259statewide training curricula to improve provider competency in the delivery of health and social
260support services to LGBTQ parents; (iv) examine the extent to which out-of-pocket cost
261associated with becoming a parent is impacted by sexual orientation and gender identity; (v)
262examine policies and practices used by cryobanks related to known donors for non-traditional
263families and LGBTQ donors; (vi) recommend best practices for increasing access to services and
264eliminating disparities; (vii) make recommendations to improve resources available to LGBTQ
265individuals relative to parentage, including but not limited to adoption, surrogacy and assistive
266reproductive technology; and (viii) make recommendations relative to education for providers of
267care and services to increase cultural competency and referrals to relevant resources.
268 (b) The office, in formulating its recommendations, shall take into account the best
269policies and practices in other states and jurisdictions. The office may consult experts, hold
270regular public meetings, fact-finding hearings and other public forums as it considers necessary.
271 (c) The study may be conducted by an entity with a demonstrated capacity to deliver
272research results passing an academic peer-review process in analyzing both quantitative and
273qualitative data and to communicate study results in an accessible manner.
274 (d) The office shall receive data to complete the charge of this study under memorandums
275of understanding with the center for health information and analysis established under chapter 14 of 17
27612C of the General Laws, the group insurance commission established under chapter 32A of the
277General Laws and MassHealth established under chapter 118E of the General Laws,
278respectively.
279 (e) The office shall submit the findings of the study to clerks of the senate and house of
280representatives, the joint committee on public health, the joint committee on health care
281financing, the joint committee on children, youth, and families and the house and senate
282committees on ways and means not later than December 31, 2026.
283 SECTION 12. Section 4OO of chapter 176G, as appearing in section 150 of chapter 140
284of the acts of 2024, is hereby amended by inserting after the word “tissue”, in subsection (b), the
285following words:- , provided that coverage for such storage shall extend until the individual
286reaches the age of 35, or for a period of 5 years, whichever is later
287 SECTION 13. Chapter 176G of the General Laws is hereby amended by inserting after
288section 4OO the following section:-
289 Section 4PP. (a) For purposes of this section, the following terms shall have the following
290meanings unless the context clearly requires otherwise:
291 “Fertility diagnostic care”, procedures, products, genetic testing, medications and
292services intended to provide information and counseling about an individual’s fertility, including
293laboratory assessments and imaging studies.
294 “Fertility treatment”, procedures, products, genetic testing, medications and services,
295including but not limited to in vitro fertilization, intended to achieve a pregnancy that results in a
296live birth and that are provided in a manner consistent with established medical practice and 15 of 17
297professional guidelines published by the American Society for Reproductive Medicine, its
298successor organization, or a comparable organization, including preconception care,
299procurement, cryopreservation and storage of gametes, embryos or other reproductive tissue.
300 “Infertility”, any of the following: (i) a licensed physician’s findings, based on a patient’s
301medical, sexual, and reproductive history, age, physical findings, diagnostic testing, or any
302combination of these factors; (ii) the need for medical intervention, including, but not limited to,
303the use of donor gametes or donor embryos in order to achieve a successful pregnancy either as
304an individual or with a partner; or (iii) the inability to establish a pregnancy after regular,
305unprotected sexual intercourse for a period of no more than twelve months for an intended
306gestational parent under the age of 35 and of no more than 6 months for an intended gestational
307parent who is 35 years of age or older, provided that pregnancy resulting in miscarriage or
308stillbirth does not restart said 12-month or 6-month time period, (iv) an individual’s increased
309risk, independently or with the individual’s partner, of transmitting a serious, inheritable genetic
310or chromosomal abnormality to a child; or (v) as otherwise defined by the American Society of
311Reproductive Medicine or its successor organization.
312 (b) Any health maintenance contract shall provide, to the same extent that benefits are
313provided for other pregnancy-related procedures and subject to the other terms and conditions of
314the subscription certificate, coverage for fertility diagnostic care and fertility treatment for
315individuals residing within the commonwealth diagnosed with infertility as defined in subsection
316(a), performed by any licensed medical providers acting within the scope of practice for their
317profession, including physicians, nurse practitioners, certified nurse-midwives and licensed
318certified professional midwives. 16 of 17
319 (c) A policy that provides coverage for services required under this section shall cover: (i)
320no fewer than four completed oocyte retrievals; (ii) unlimited embryo transfers from retrievals
321covered under this section or from any other completed oocyte retrieval; (iii) unlimited cycles of
322intrauterine insemination; and (iv) unlimited intracervical insemination. No policy shall be
323required to provide coverage for any nonmedical costs relating to the procurement of gametes,
324donor embryos, or surrogacy services.
325 (d) Said coverage may not include any of the following: (i) any exclusion, limitation or
326other restriction on coverage of fertility medications that are different from those imposed on
327other prescription medications; (ii) any exclusion or denial of coverage of any fertility treatment
328based on a covered individual’s participation in fertility services provided by a third party,
329including gestational carriers, surrogates and the donation or use of said thirty party’s genetic
330material; and (iii) any deductible, copayment, coinsurance, benefit maximum or other limitation
331on coverage for services rendered pursuant to this section that are different from those imposed
332upon services not relating to infertility or fertility treatment.
333 SECTION 14. Section 17U of chapter 32A shall take effect one year following enactment
334of the legislation.
335 SECTION 15. The training curriculum established pursuant to section 5P of chapter 112
336of the General Laws shall be completed within 9 months of enactment of the legislation.
337 SECTION 16. Section 10AA of chapter 118E shall take effect one year following
338enactment of the legislation.
339 SECTION 16. Section 47H of chapter 175 shall take effect one year following enactment
340of the legislation. 17 of 17
341 SECTION 17. Section 8K of chapter 176A shall take effect one year following enactment
342of the legislation.
343 SECTION 18. Section 4J of chapter 176B shall take effect one year following enactment
344of the legislation.
345 SECTION 18. Section 4PP of chapter 176G shall take effect one year following
346enactment of the legislation.